Joseph Sakai
Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conduct Disorder | 29 | 2025 | 158 | 8.820 |
Why?
| | Substance-Related Disorders | 31 | 2025 | 1112 | 3.870 |
Why?
| | Adolescent Behavior | 10 | 2025 | 498 | 3.360 |
Why?
| | Emotions | 13 | 2025 | 583 | 3.150 |
Why?
| | Empathy | 10 | 2025 | 184 | 3.080 |
Why?
| | Antisocial Personality Disorder | 14 | 2025 | 123 | 2.700 |
Why?
| | Theory of Mind | 3 | 2025 | 15 | 2.520 |
Why?
| | Psychiatry | 5 | 2026 | 197 | 1.630 |
Why?
| | Executive Function | 3 | 2025 | 472 | 1.420 |
Why?
| | Cognition | 6 | 2025 | 1286 | 1.370 |
Why?
| | Cannabis | 5 | 2025 | 518 | 1.320 |
Why?
| | Morals | 2 | 2023 | 85 | 1.220 |
Why?
| | Students, Medical | 4 | 2023 | 380 | 1.150 |
Why?
| | Mental Disorders | 9 | 2025 | 1188 | 1.130 |
Why?
| | Risk-Taking | 8 | 2023 | 325 | 1.090 |
Why?
| | Adolescent | 50 | 2025 | 22825 | 1.080 |
Why?
| | Social Behavior | 2 | 2025 | 287 | 1.060 |
Why?
| | Helping Behavior | 2 | 2019 | 20 | 1.040 |
Why?
| | Brain | 11 | 2025 | 3009 | 0.920 |
Why?
| | Alcoholism | 12 | 2026 | 838 | 0.900 |
Why?
| | Connectome | 2 | 2023 | 101 | 0.890 |
Why?
| | Altruism | 2 | 2023 | 28 | 0.880 |
Why?
| | Affect | 2 | 2025 | 323 | 0.880 |
Why?
| | Medical Marijuana | 3 | 2017 | 122 | 0.840 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 3 | 2010 | 62 | 0.810 |
Why?
| | Career Mobility | 1 | 2024 | 68 | 0.810 |
Why?
| | Clinical Clerkship | 2 | 2023 | 109 | 0.800 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2024 | 149 | 0.790 |
Why?
| | Awards and Prizes | 1 | 2024 | 72 | 0.780 |
Why?
| | Opioid-Related Disorders | 3 | 2023 | 617 | 0.770 |
Why?
| | Psychology, Adolescent | 2 | 2016 | 62 | 0.750 |
Why?
| | Binge Drinking | 1 | 2023 | 45 | 0.730 |
Why?
| | Models, Psychological | 1 | 2023 | 295 | 0.680 |
Why?
| | Cerebral Cortex | 5 | 2017 | 483 | 0.680 |
Why?
| | Motivation | 2 | 2025 | 615 | 0.680 |
Why?
| | Faculty, Medical | 1 | 2024 | 308 | 0.660 |
Why?
| | Marijuana Abuse | 5 | 2017 | 215 | 0.660 |
Why?
| | Decision Making | 7 | 2017 | 994 | 0.650 |
Why?
| | Tobacco Products | 1 | 2022 | 90 | 0.640 |
Why?
| | Vaping | 1 | 2022 | 81 | 0.630 |
Why?
| | Humans | 83 | 2026 | 147293 | 0.620 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 112 | 0.620 |
Why?
| | Male | 60 | 2026 | 73950 | 0.600 |
Why?
| | Prescription Drug Misuse | 1 | 2020 | 53 | 0.580 |
Why?
| | Sexual and Gender Minorities | 1 | 2023 | 272 | 0.580 |
Why?
| | Magnetic Resonance Imaging | 16 | 2025 | 3980 | 0.560 |
Why?
| | Female | 56 | 2026 | 80076 | 0.550 |
Why?
| | Education, Medical | 1 | 2021 | 277 | 0.540 |
Why?
| | Gray Matter | 2 | 2015 | 97 | 0.520 |
Why?
| | Nerve Net | 2 | 2025 | 288 | 0.490 |
Why?
| | Gift Giving | 1 | 2016 | 9 | 0.470 |
Why?
| | Case-Control Studies | 11 | 2023 | 3660 | 0.470 |
Why?
| | Affective Symptoms | 1 | 2016 | 53 | 0.460 |
Why?
| | Physicians | 1 | 2024 | 961 | 0.450 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2014 | 2223 | 0.440 |
Why?
| | Depression | 2 | 2024 | 1599 | 0.420 |
Why?
| | Reward | 4 | 2025 | 248 | 0.420 |
Why?
| | Problem Behavior | 1 | 2015 | 101 | 0.400 |
Why?
| | Suicide | 1 | 2021 | 737 | 0.390 |
Why?
| | Alcohol Drinking | 5 | 2026 | 858 | 0.380 |
Why?
| | Craving | 2 | 2026 | 42 | 0.380 |
Why?
| | Receptors, GABA-A | 2 | 2014 | 138 | 0.370 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 20 | 0.350 |
Why?
| | Marijuana Smoking | 2 | 2014 | 249 | 0.340 |
Why?
| | Psychomotor Performance | 1 | 2013 | 326 | 0.320 |
Why?
| | United States | 13 | 2024 | 16313 | 0.310 |
Why?
| | Sex Characteristics | 3 | 2023 | 799 | 0.310 |
Why?
| | Ethanol | 2 | 2023 | 634 | 0.300 |
Why?
| | Receptors, Dopamine D2 | 2 | 2007 | 93 | 0.290 |
Why?
| | Marijuana Use | 2 | 2025 | 222 | 0.280 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 5 | 2009 | 232 | 0.280 |
Why?
| | Legislation, Drug | 2 | 2022 | 73 | 0.260 |
Why?
| | Mental Health | 3 | 2025 | 813 | 0.260 |
Why?
| | Games, Experimental | 2 | 2019 | 12 | 0.260 |
Why?
| | Adult | 27 | 2026 | 41405 | 0.240 |
Why?
| | Polymorphism, Genetic | 3 | 2006 | 615 | 0.240 |
Why?
| | Tegafur | 1 | 2026 | 12 | 0.240 |
Why?
| | Oxonic Acid | 1 | 2026 | 13 | 0.240 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2026 | 11 | 0.240 |
Why?
| | Neuroimaging | 3 | 2019 | 309 | 0.240 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 126 | 0.230 |
Why?
| | Aggression | 2 | 2009 | 180 | 0.230 |
Why?
| | Literacy | 1 | 2026 | 13 | 0.230 |
Why?
| | Amphetamine-Related Disorders | 2 | 2025 | 53 | 0.230 |
Why?
| | Corneal Diseases | 1 | 2026 | 48 | 0.230 |
Why?
| | Child | 14 | 2025 | 22979 | 0.230 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2026 | 108 | 0.230 |
Why?
| | Reproducibility of Results | 5 | 2023 | 3448 | 0.230 |
Why?
| | Curriculum | 2 | 2026 | 1082 | 0.220 |
Why?
| | Blood Chemical Analysis | 1 | 2006 | 109 | 0.220 |
Why?
| | Monitoring, Ambulatory | 1 | 2006 | 89 | 0.220 |
Why?
| | Young Adult | 9 | 2024 | 14437 | 0.220 |
Why?
| | Colorado | 9 | 2020 | 4591 | 0.210 |
Why?
| | Glucagon-Like Peptides | 1 | 2026 | 76 | 0.210 |
Why?
| | Brain Mapping | 5 | 2019 | 550 | 0.210 |
Why?
| | Substance Abuse Detection | 1 | 2006 | 112 | 0.210 |
Why?
| | Methamphetamine | 1 | 2025 | 75 | 0.200 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 794 | 0.200 |
Why?
| | Guilt | 1 | 2023 | 10 | 0.200 |
Why?
| | Double-Blind Method | 2 | 2026 | 2080 | 0.200 |
Why?
| | Charities | 1 | 2023 | 12 | 0.190 |
Why?
| | Reaction Time | 1 | 2025 | 438 | 0.190 |
Why?
| | Marriage | 1 | 2004 | 123 | 0.190 |
Why?
| | Central Nervous System Stimulants | 1 | 2025 | 187 | 0.190 |
Why?
| | Siblings | 3 | 2009 | 197 | 0.190 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 342 | 0.190 |
Why?
| | Happiness | 1 | 2022 | 24 | 0.180 |
Why?
| | Perioperative Care | 1 | 2025 | 231 | 0.180 |
Why?
| | Odds Ratio | 2 | 2020 | 1084 | 0.180 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1253 | 0.180 |
Why?
| | Fellowships and Scholarships | 1 | 2026 | 357 | 0.180 |
Why?
| | Impulsive Behavior | 2 | 2015 | 145 | 0.170 |
Why?
| | Faculty | 1 | 2023 | 150 | 0.170 |
Why?
| | Unsafe Sex | 2 | 2020 | 62 | 0.170 |
Why?
| | Cannabidiol | 1 | 2024 | 142 | 0.170 |
Why?
| | Electronics | 1 | 2022 | 65 | 0.170 |
Why?
| | Deep Brain Stimulation | 1 | 2025 | 222 | 0.170 |
Why?
| | Linkage Disequilibrium | 4 | 2008 | 259 | 0.170 |
Why?
| | Genetic Predisposition to Disease | 2 | 2008 | 2458 | 0.170 |
Why?
| | Prevalence | 7 | 2024 | 2889 | 0.170 |
Why?
| | Sleep Wake Disorders | 1 | 2025 | 315 | 0.160 |
Why?
| | Education, Medical, Graduate | 1 | 2026 | 568 | 0.160 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 6011 | 0.160 |
Why?
| | Enuresis | 1 | 2000 | 3 | 0.160 |
Why?
| | Family | 4 | 2009 | 690 | 0.160 |
Why?
| | Phenotype | 4 | 2010 | 3216 | 0.150 |
Why?
| | Educational Measurement | 1 | 2023 | 332 | 0.150 |
Why?
| | Genotype | 5 | 2014 | 1875 | 0.150 |
Why?
| | Tandem Repeat Sequences | 1 | 1999 | 23 | 0.150 |
Why?
| | Receptors, Dopamine | 1 | 1999 | 19 | 0.150 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 69 | 0.150 |
Why?
| | Biomedical Research | 1 | 2026 | 723 | 0.150 |
Why?
| | Data Collection | 2 | 2014 | 652 | 0.140 |
Why?
| | Substance Abuse, Intravenous | 2 | 2013 | 131 | 0.140 |
Why?
| | Tobacco Use | 1 | 2020 | 68 | 0.140 |
Why?
| | Physician Incentive Plans | 1 | 2018 | 8 | 0.140 |
Why?
| | Education, Distance | 1 | 2019 | 59 | 0.140 |
Why?
| | Fear | 1 | 2022 | 373 | 0.140 |
Why?
| | Social Stigma | 1 | 2021 | 177 | 0.140 |
Why?
| | Logistic Models | 3 | 2020 | 2142 | 0.140 |
Why?
| | Adolescent Development | 1 | 2019 | 73 | 0.140 |
Why?
| | Professional-Patient Relations | 1 | 2019 | 149 | 0.140 |
Why?
| | Patient Acceptance of Health Care | 1 | 2005 | 895 | 0.140 |
Why?
| | Multimodal Imaging | 1 | 2019 | 138 | 0.140 |
Why?
| | Tuberculin Test | 1 | 1998 | 36 | 0.130 |
Why?
| | Sex Factors | 4 | 2017 | 2136 | 0.130 |
Why?
| | Sleep | 1 | 2025 | 895 | 0.130 |
Why?
| | Automobile Driving | 1 | 2020 | 159 | 0.130 |
Why?
| | Physicians, Family | 1 | 2018 | 179 | 0.130 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1998 | 127 | 0.130 |
Why?
| | Clinical Competence | 2 | 2023 | 1260 | 0.120 |
Why?
| | Comorbidity | 7 | 2015 | 1672 | 0.120 |
Why?
| | Organ Size | 2 | 2015 | 465 | 0.120 |
Why?
| | Writing | 1 | 2018 | 101 | 0.120 |
Why?
| | Surveys and Questionnaires | 6 | 2018 | 6164 | 0.120 |
Why?
| | Violence | 1 | 2019 | 282 | 0.120 |
Why?
| | Drug Prescriptions | 1 | 2018 | 293 | 0.120 |
Why?
| | Moral Obligations | 1 | 2016 | 15 | 0.120 |
Why?
| | Risk Factors | 7 | 2026 | 11017 | 0.120 |
Why?
| | Chi-Square Distribution | 2 | 2009 | 528 | 0.120 |
Why?
| | California | 1 | 2017 | 477 | 0.120 |
Why?
| | Photic Stimulation | 1 | 2017 | 266 | 0.120 |
Why?
| | Mental Competency | 1 | 2015 | 28 | 0.110 |
Why?
| | Suicide, Attempted | 1 | 2020 | 430 | 0.110 |
Why?
| | Research Subjects | 1 | 2015 | 41 | 0.110 |
Why?
| | Suicidal Ideation | 1 | 2021 | 590 | 0.110 |
Why?
| | Genetics, Population | 2 | 2007 | 226 | 0.110 |
Why?
| | Middle Aged | 13 | 2026 | 36821 | 0.110 |
Why?
| | Psychotic Disorders | 1 | 1998 | 199 | 0.110 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2000 | 303 | 0.110 |
Why?
| | Self Report | 2 | 2020 | 887 | 0.110 |
Why?
| | Parents | 1 | 2004 | 1428 | 0.110 |
Why?
| | Frontal Lobe | 2 | 2015 | 161 | 0.110 |
Why?
| | Gambling | 1 | 2015 | 29 | 0.110 |
Why?
| | Internship and Residency | 1 | 2026 | 1279 | 0.110 |
Why?
| | Learning | 1 | 2019 | 446 | 0.110 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 1999 | 434 | 0.110 |
Why?
| | Biological Specimen Banks | 1 | 2015 | 137 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2018 | 718 | 0.100 |
Why?
| | Informed Consent | 1 | 2015 | 200 | 0.100 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2007 | 60 | 0.090 |
Why?
| | Juvenile Delinquency | 3 | 2008 | 95 | 0.090 |
Why?
| | Accidents, Traffic | 1 | 2014 | 195 | 0.090 |
Why?
| | Limbic System | 1 | 2012 | 55 | 0.090 |
Why?
| | Attitude | 1 | 2014 | 260 | 0.090 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2019 | 153 | 0.090 |
Why?
| | Longitudinal Studies | 5 | 2014 | 3027 | 0.080 |
Why?
| | DNA Primers | 2 | 2010 | 505 | 0.080 |
Why?
| | Alleles | 2 | 2007 | 909 | 0.080 |
Why?
| | Follow-Up Studies | 3 | 2026 | 5476 | 0.080 |
Why?
| | Genomics | 1 | 2015 | 839 | 0.080 |
Why?
| | Hawaii | 1 | 2010 | 38 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 1167 | 0.080 |
Why?
| | Nuclear Family | 1 | 2009 | 50 | 0.070 |
Why?
| | Age Factors | 2 | 2014 | 3372 | 0.070 |
Why?
| | Gene Frequency | 1 | 2010 | 498 | 0.070 |
Why?
| | Sexual Behavior | 1 | 2013 | 502 | 0.070 |
Why?
| | Urban Population | 1 | 2012 | 502 | 0.070 |
Why?
| | Receptors, Serotonin | 2 | 2000 | 34 | 0.070 |
Why?
| | Base Sequence | 2 | 2010 | 2175 | 0.070 |
Why?
| | Diseases in Twins | 1 | 2009 | 116 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1759 | 0.070 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 59 | 0.060 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 14 | 0.060 |
Why?
| | Acculturation | 1 | 2007 | 55 | 0.060 |
Why?
| | Mouth Mucosa | 1 | 2007 | 85 | 0.060 |
Why?
| | Transcription, Genetic | 2 | 2007 | 1456 | 0.060 |
Why?
| | Twins, Dizygotic | 1 | 2007 | 108 | 0.060 |
Why?
| | Taq Polymerase | 1 | 2006 | 8 | 0.060 |
Why?
| | Inheritance Patterns | 1 | 2006 | 47 | 0.060 |
Why?
| | Twins, Monozygotic | 1 | 2007 | 133 | 0.060 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 149 | 0.060 |
Why?
| | Hospitals, Veterans | 1 | 2007 | 259 | 0.060 |
Why?
| | Water Loss, Insensible | 1 | 2006 | 4 | 0.060 |
Why?
| | Japan | 1 | 2026 | 149 | 0.060 |
Why?
| | Residential Treatment | 1 | 2006 | 30 | 0.060 |
Why?
| | Breath Tests | 1 | 2006 | 77 | 0.060 |
Why?
| | Demography | 1 | 2006 | 283 | 0.050 |
Why?
| | Reference Values | 1 | 2006 | 800 | 0.050 |
Why?
| | Regression Analysis | 1 | 2007 | 1003 | 0.050 |
Why?
| | Alcoholic Intoxication | 1 | 2006 | 77 | 0.050 |
Why?
| | Tobacco Use Disorder | 1 | 2006 | 217 | 0.050 |
Why?
| | Drug Combinations | 1 | 2026 | 399 | 0.050 |
Why?
| | Attitude of Health Personnel | 2 | 2018 | 1220 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2006 | 572 | 0.050 |
Why?
| | Twins | 1 | 2025 | 152 | 0.050 |
Why?
| | Hospitals, University | 1 | 2004 | 176 | 0.050 |
Why?
| | Smoking | 2 | 2012 | 1483 | 0.050 |
Why?
| | Equipment Design | 1 | 2006 | 527 | 0.050 |
Why?
| | Acute Coronary Syndrome | 1 | 2007 | 299 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 789 | 0.050 |
Why?
| | Administration, Oral | 1 | 2026 | 874 | 0.050 |
Why?
| | Genetic Variation | 2 | 1999 | 995 | 0.050 |
Why?
| | Statistics, Nonparametric | 1 | 2004 | 430 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2026 | 8430 | 0.050 |
Why?
| | Canada | 1 | 2024 | 435 | 0.050 |
Why?
| | Incidence | 2 | 2026 | 2954 | 0.050 |
Why?
| | DNA | 2 | 2007 | 1444 | 0.040 |
Why?
| | Adaptation, Psychological | 1 | 2007 | 736 | 0.040 |
Why?
| | Aged | 5 | 2026 | 26514 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 2030 | 0.040 |
Why?
| | Prospective Studies | 3 | 2026 | 8164 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2026 | 11947 | 0.040 |
Why?
| | Psychometrics | 3 | 2009 | 739 | 0.040 |
Why?
| | Interview, Psychological | 2 | 2012 | 95 | 0.040 |
Why?
| | Substance Abuse Treatment Centers | 2 | 2012 | 49 | 0.040 |
Why?
| | Adenoidectomy | 1 | 2000 | 82 | 0.040 |
Why?
| | Receptors, LDL | 1 | 1998 | 53 | 0.030 |
Why?
| | Multigene Family | 1 | 1999 | 210 | 0.030 |
Why?
| | Child Abuse | 1 | 2004 | 558 | 0.030 |
Why?
| | Electronic Mail | 1 | 2018 | 63 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2024 | 606 | 0.030 |
Why?
| | Genetic Markers | 1 | 1999 | 338 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 160 | 0.030 |
Why?
| | Health Surveys | 2 | 2012 | 522 | 0.030 |
Why?
| | Attention | 1 | 2021 | 464 | 0.030 |
Why?
| | Tonsillectomy | 1 | 2000 | 106 | 0.030 |
Why?
| | HIV Infections | 1 | 2013 | 3235 | 0.030 |
Why?
| | Epidemics | 1 | 2018 | 96 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 344 | 0.030 |
Why?
| | Internal-External Control | 1 | 2017 | 74 | 0.030 |
Why?
| | Cues | 1 | 2019 | 329 | 0.030 |
Why?
| | Anxiety | 1 | 2024 | 1149 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2004 | 2973 | 0.030 |
Why?
| | Game Theory | 1 | 2015 | 7 | 0.030 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2015 | 22 | 0.030 |
Why?
| | Education, Medical, Undergraduate | 1 | 2018 | 208 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 7173 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2008 | 2017 | 0.020 |
Why?
| | Condoms | 1 | 2013 | 102 | 0.020 |
Why?
| | Radiography | 1 | 2015 | 862 | 0.020 |
Why?
| | Heroin Dependence | 1 | 2012 | 33 | 0.020 |
Why?
| | Gyrus Cinguli | 1 | 2012 | 99 | 0.020 |
Why?
| | Family Conflict | 1 | 2012 | 43 | 0.020 |
Why?
| | Sexual Partners | 1 | 2013 | 195 | 0.020 |
Why?
| | Schizophrenia | 1 | 1996 | 489 | 0.020 |
Why?
| | Family Relations | 1 | 2012 | 90 | 0.020 |
Why?
| | Cocaine-Related Disorders | 1 | 2012 | 133 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 1046 | 0.020 |
Why?
| | Pregnancy | 1 | 2024 | 7274 | 0.020 |
Why?
| | Neural Pathways | 1 | 2012 | 320 | 0.020 |
Why?
| | Social Environment | 1 | 2012 | 254 | 0.020 |
Why?
| | Patient Admission | 1 | 2012 | 220 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1379 | 0.020 |
Why?
| | Cerebellum | 1 | 2011 | 227 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2007 | 17560 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1550 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 134 | 0.020 |
Why?
| | Receptor, Serotonin, 5-HT2A | 2 | 2000 | 18 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2012 | 1145 | 0.020 |
Why?
| | Hippocampus | 1 | 2012 | 989 | 0.020 |
Why?
| | Sex Distribution | 1 | 2007 | 390 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 3784 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 369 | 0.010 |
Why?
| | Health Services Research | 1 | 2007 | 392 | 0.010 |
Why?
| | Age of Onset | 1 | 2006 | 568 | 0.010 |
Why?
| | Models, Genetic | 1 | 2007 | 536 | 0.010 |
Why?
| | Survival Analysis | 1 | 2007 | 1386 | 0.010 |
Why?
| | Nicotine | 1 | 2006 | 336 | 0.010 |
Why?
| | Schools | 1 | 2006 | 453 | 0.010 |
Why?
| | Perception | 1 | 2006 | 378 | 0.010 |
Why?
| | Molecular Sequence Data | 2 | 1998 | 2886 | 0.010 |
Why?
| | United States Department of Veterans Affairs | 1 | 2007 | 793 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2007 | 1043 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1481 | 0.010 |
Why?
| | Algorithms | 1 | 2008 | 1868 | 0.010 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2000 | 8 | 0.010 |
Why?
| | Receptor, Serotonin, 5-HT2C | 1 | 2000 | 14 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2007 | 1213 | 0.010 |
Why?
| | Threonine | 1 | 1998 | 44 | 0.010 |
Why?
| | Cricetinae | 1 | 1998 | 305 | 0.010 |
Why?
| | Glycosylation | 1 | 1998 | 176 | 0.010 |
Why?
| | Organ Specificity | 1 | 1998 | 310 | 0.010 |
Why?
| | Serine | 1 | 1998 | 143 | 0.010 |
Why?
| | Rabbits | 1 | 1998 | 654 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 980 | 0.010 |
Why?
| | Alternative Splicing | 1 | 1998 | 248 | 0.010 |
Why?
| | Transfection | 1 | 1998 | 930 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 1998 | 480 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1998 | 1371 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1998 | 2134 | 0.010 |
Why?
| | Myocardium | 1 | 1998 | 947 | 0.010 |
Why?
| | Cell Line | 1 | 1998 | 2832 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 1998 | 1798 | 0.000 |
Why?
| | Animals | 1 | 1998 | 38410 | 0.000 |
Why?
|
|
Sakai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|